Published on
January 6, 2023
- 19:26 GMT
RDEA Pilot Program Disclosure Agreement | Rare Disease Endpoint Advancement Pilot Program
Before FDA grants the initial meeting under the RDEA Pilot Program, the Agency and the sponsor must agree on the information that FDA may disclose publicly. In a disclosure agreement with sponsors, FDA intends to include, as applicable, the following …
Distribution channels:
Healthcare & Pharmaceuticals Industry
